In this conversation, Phillip Chang, M.D., chief medical officer of CommonSpirit Health, shares insights on measuring data and quality, leading clinicians through change and building a more ...
Elsunersen demonstrated placebo-adjusted seizure reduction from baseline of 77% (p=0.015) 71% of elsunersen-treated patients achieved >50% seizure reduction by period 6, with sustained benefit ...
Transdermal oestradiol patches are non-inferior to luteinising hormone-releasing hormone agonists for metastasis free survival in locally advanced prostate cancer, a study shows.
Neurocrine Biosciences is buying Soleno Therapeutics for $2.9 billion, picking up an approved medicine for a rare disease ...
Immunocore to present at the 25th Annual Needham Virtual Healthcare Conference (OXFORDSHIRE, England & RADNOR, Penn. & GAITHERSBURG, Md., US, 06 April 2026) Immunocore Holdings plc (Nasdaq: IMCR) ...
For patients facing severe illness and suffering, the option is framed as an act of compassion. But its rapid expansion ...
SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) ('Scienture”) a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and ...
Avalyn Pharma Inc., ('Avalyn” or the 'Company”), a clinical-stage biopharmaceutical company pioneering inhaled therapies to ...
Elite DNA Behavioral Health, a comprehensive behavioral and mental health care provider, has opened its first Virginia location in Chesapeake. Read about more business news throughout Hampton Roads.
The secretary of Indiana’s Family and Social Services Administration wants to change how hospitals purchase discounted drugs ...
Krissy Lapczynski couldn’t finish her training run for the Boston Marathon and she told her 1,191 followers on Instagram all about her failure. Lapczynski, a Pharmac ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results